1. Home
  2. RCKT vs AIOT Comparison

RCKT vs AIOT Comparison

Compare RCKT & AIOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • AIOT
  • Stock Information
  • Founded
  • RCKT 1999
  • AIOT 1993
  • Country
  • RCKT United States
  • AIOT United States
  • Employees
  • RCKT N/A
  • AIOT N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • AIOT Telecommunications Equipment
  • Sector
  • RCKT Health Care
  • AIOT Telecommunications
  • Exchange
  • RCKT Nasdaq
  • AIOT Nasdaq
  • Market Cap
  • RCKT 764.5M
  • AIOT 785.8M
  • IPO Year
  • RCKT N/A
  • AIOT N/A
  • Fundamental
  • Price
  • RCKT $7.18
  • AIOT $5.21
  • Analyst Decision
  • RCKT Strong Buy
  • AIOT Strong Buy
  • Analyst Count
  • RCKT 10
  • AIOT 4
  • Target Price
  • RCKT $44.10
  • AIOT $11.25
  • AVG Volume (30 Days)
  • RCKT 3.2M
  • AIOT 1.2M
  • Earning Date
  • RCKT 05-08-2025
  • AIOT 05-20-2025
  • Dividend Yield
  • RCKT N/A
  • AIOT N/A
  • EPS Growth
  • RCKT N/A
  • AIOT N/A
  • EPS
  • RCKT N/A
  • AIOT N/A
  • Revenue
  • RCKT N/A
  • AIOT $292,953,000.00
  • Revenue This Year
  • RCKT N/A
  • AIOT $174.10
  • Revenue Next Year
  • RCKT N/A
  • AIOT $22.01
  • P/E Ratio
  • RCKT N/A
  • AIOT N/A
  • Revenue Growth
  • RCKT N/A
  • AIOT 119.05
  • 52 Week Low
  • RCKT $4.55
  • AIOT $3.70
  • 52 Week High
  • RCKT $26.98
  • AIOT $8.71
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 46.92
  • AIOT 52.19
  • Support Level
  • RCKT $6.21
  • AIOT $4.91
  • Resistance Level
  • RCKT $8.26
  • AIOT $5.33
  • Average True Range (ATR)
  • RCKT 0.58
  • AIOT 0.23
  • MACD
  • RCKT 0.03
  • AIOT 0.07
  • Stochastic Oscillator
  • RCKT 28.05
  • AIOT 84.49

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.

About AIOT PowerFleet Inc. Common Stock

PowerFleet Inc is engaged in Internet-of-Things (IoT) solutions providing valuable business intelligence for managing high-value enterprise assets that improve operational efficiencies. It provide critical information that powers unified operations throughout organizations. It is solving the challenge of inefficient data collection, real-time visibility, and analysis that leads to transformative business operations. Its SaaS cloud-based applications take data from IoT devices and ecosystem of third-party and partner applications to present actionable information for customer.

Share on Social Networks: